1. Home
  2. URG vs BNTC Comparison

URG vs BNTC Comparison

Compare URG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ur Energy Inc (Canada)

URG

Ur Energy Inc (Canada)

HOLD

Current Price

$1.11

Market Cap

608.7M

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$9.85

Market Cap

396.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
URG
BNTC
Founded
2004
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
608.7M
396.3M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
URG
BNTC
Price
$1.11
$9.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$2.57
★ $27.67
AVG Volume (30 Days)
★ 5.3M
126.0K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.67
EPS
★ N/A
N/A
Revenue
★ $27,207,000.00
N/A
Revenue This Year
$200.42
N/A
Revenue Next Year
$98.46
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.09
$9.26
52 Week High
$2.35
$16.76

Technical Indicators

Market Signals
Indicator
URG
BNTC
Relative Strength Index (RSI) 29.63 30.39
Support Level N/A N/A
Resistance Level $1.46 $13.49
Average True Range (ATR) 0.05 0.73
MACD -0.02 -0.19
Stochastic Oscillator 6.90 12.77

Price Performance

Historical Comparison
URG
BNTC

About URG Ur Energy Inc (Canada)

Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project; Shirley Basin; Other U.S. Projects.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: